A multicenter study is under way to investigate the efficacy of allografting of embryonic mesencephalic neurons in a pig model of Parkinson's disease. We have first established that a stable parkinsonian syndrome can be established by l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP) intoxication of adult male Gottingen minipigs. We are now using positron emission tomography (PET) methods for testing the physiologi cal responses to MPTP intoxication and the time course of the response to several treatment strategies. We now report preliminary results obtained in 11 pigs employed in the initial phase of the study; the completed study shall ultimately include 30 pigs. Animals were randomly assigned to one of five groups: 1) Control, 2) MPTP intoxication, 3) MPTP intoxication followed by allograft, 4) MPTP intoxication followed by allo graft with immunosuppression, and 5) MPTP intoxication followed by allograft with immunosuppression and co-grafting of immortalized HiB5 cells, which had been manipulated to secrete glia cell line-derived neurotrophic factor (GDNF) (=2 ng GDNF/h/10 5 cells). MPTP was administered (1 mg/kg/day, SC) for 7-10 days until the pigs had developed mild parkinsonian symptoms of muscle rigidity, hypokinesia, and impaired coordination, especially of the hind limbs. Approximately 2 weeks after the last MPTP dose, animals received a Tl-weighted magnetic resonance imaging (MRI) scan, and a series of dynamic PET recordings. After the first series of PET scans, four grafts of porcine embryonic mesencephalic tissue (E28 days) were placed in each striatum of some MPTP-intoxicated pigs, using MRI-based stereotactic techniques. Immunosuppression of some animals with cyclosporin and prednisolone began just prior to surgery. Two more series of PET scans were performed at 4-month intervals after surgery. After the last scans, pigs were killed and the brains were perfused for unbiased stereological examination of cytological and histochemical markers in striatum and substantial nigra. The behavioral impairment of the animals (the "Parkinson's score") had been evaluated throughout the 8-month period. Kinetic analysis of the first set of PET scans has indicated that the rate constant for the decarboxylation of FDOPA in catecholamine fibers was reduced by 33% in striatum of the mildly parkinsonian pigs. The rate of association of [ n C]NS-2214 to catecholamine uptake sites was reduced by 62% in the same groups of pigs. No significant difference was found in the binding potential of [ n C]raclopride to the dopamine D 2 -like receptors in striatum of the MPTP-intoxicated versus control pigs. These preliminary results are suggestive that the activity of DOPA decarboxylase may be upregulated in the partially denervated pig striatum.
INTRODUCTION
Current pharmacological treatments are ineffective in abating the progression of Parkinson's disease, a dis abling neurodegenernative disorder affecting 1% of the worldwide population aged more than 70 years. The mo tor symptoms of Parkinson's disease, including tremor at rest, rigidity, hypokinesia, and postural imbalance (38) , are linked primarily to pathological degeneration of pigmented neurons of the substantia nigra and the presence of neuronal Lewy body inclusions (20, 43) , al though other neurochemical markers are also affected (5, 20, 48) . The loss of the nigrostriatal neurons results in substantial depletion of dopamine in the caudate and putamen, the main projection areas in the basal ganglia.
This observation first provided the basis for the rational ized treatment of Parkinson's disease with L-dopa, the immediate precursor for dopamine. Monotherapy with L-dopa is highly effective in the early stages of the dis ease (2) , but continued disease progression often re quires less satisfactory polypharmacy. The early success of L-dopa treatment usually diminishes after 5-10 years of therapy and is replaced by fluctuating responses, characterized by periods of akinesia alternating with epi sodes of dyskinisa (38) . The current lack of useful inter ventions for advanced Parkinson's disease has lead to the search for new therapeutic strategies.
Successful experiments with transplantation of imma ture dopamine neurons to rodents with an experimental model of Parkinson's disease (3, 4) led to clinical testing of this new treatment (35, 36) . The use of human fetal neurons for transplantation (54) has been established as a promising, but still experimental, treatment. At pres ent, the logistics and the ethics related to obtaining suffi cient human fetal neurons greatly limits the availability of this treatment. Furthermore, the surgical and postop erative procedures for grafting fetal neurons to the de nervated striatum have not been optimized. Likewise, ethical concerns related to the use of human fetal tissue for treatment have stimulated a search for alternative sources for dopamine neurons (6) , and a search for means to improve the survival of grafted dopamine neu rons in situ (40) . The possible hazards of infections due to xenografting in the central nervous system must also be considered (1, 30, 51) .
The recent use of dopamine neurons obtained from fetal pig brain for experimental treatment of human Par kinson's disease (13) was attempted without complete characterization of this approach in animal models, al though results in rat have been reported (21, 29) . The overall goal of the present project is to test effects of grafting dopamine neurons obtained from embryonic pig on the physiological state of the dopamine-depleted brain, by means of positron emission tomography (PET) in conjunction with magnetic resonance imaging and histological examination postmortem. The requirements of the imaging techniques for a relatively large brain are satisfied by pigs (12) , and the effects of MPTP intoxica tion on dopamine concentrations in pig brain support the use of minipigs as an experimental model for Parkin son's disease (42) .
We use PET to characterize the physiological effects of MPTP intoxication on markers for dopamine synthe sis, dopamine receptors, and dopamine uptake sites in the brain of the Gottingen minipig, and to test the effects of grafting on these markers. In addition, we assay glia reaction and cerebral oxygen consumption 4 and 8 months after grafting ( Fig. 1 ). Neurological examination during this period is used to assess the capacity of grafted neurons to rectify impaired motor function in the pigs. Finally, the survival of the dopamine neurons at 8 months is quantified using immunohistochemical meth ods. The clinical results shall be correlated with findings in vivo and in vitro in order to estimate the minimum number of pig neurons required to normalize dopamine function. In this first report, we describe in detail the experimental design, and report initial results obtained by PET of the effect of MPTP intoxication on the cere bral activity of DOPA decarboxylase, the density of cat echolamine uptake sites, and the density of D 2 receptors 1 month after intoxication. 
ANIMALS

MPTP INTOXICATION
The experimental design requires that the pigs sur vive for 8 months with stable parkinsonian symptoms so that the effects of treatment on striatal dopaminergic markers could be assessed. The relationship between se verity of the MPTP-induced parkinsonian symptoms and PET markers was not the object of study per se. Further more, the lengthy survival requires that the animals not be incapacitated because of ethical considerations and also the risk of morbidity due to weight loss. Therefore, the MPTP intoxication regime for each pig was moni tored to produce a stable, mildly parkinsonian condition.
The behavioral score was assessed daily and used to ad just the MPTP dosage. The morning of each day of in toxication, weighed portions of MPTP hydrochloride (Novo Nordisk, Copenhagen) were placed in sterile vials, to which was added sterile saline solution, making a final MPTP concentration of 10 mg/ml as the free base. The initial daily dose was 1 mg/kg (SC). By day 4, the daily dose for some pigs was reduced to 0.7 mg/ kg (Table 1) Flow chart of the present study. Each animal undergoes a sequence of clinical investigations and imaging procedures. A total of 30 pigs will ultimately be included in the project, such that each experimental group will contain six animals as follows: group 1, healthy pigs with sham injections of saline; group 2, MPTP-intoxicated pigs with intracerebral infusion of saline; group 3, MPTP-intoxicated pigs receiving grafts of embryonic porcine mesencephalic neurons to the striatum; group 4, MPTP-intoxicated pigs likewise receiving grafts, followed by continuous immunosuppressive treatment consisting of prednisolone and cyclosporin; group 5, MPTP-intoxicated pigs receiving grafts of mesencephalic neurons, co-grafted with a conditionally immortalized GDNFproducing hippocampal cell line, followed by immunosuppressive treatment as above. The pigs in groups 2, 3, 4, and 5 all receive MPTP intoxication to establish a stable mildly parkinsonian condition. The clinical status is recorded (Behav) each month for 10 months, including just prior to the terminal PET experiments. Approximately 4 weeks after the MPTP intoxication, the pigs are investigated by PET using a series of PET tracers and by MRI. One week after the first PET scans, pigs in groups 1 and 2 receive sham grafts (TPL) directed stereotactically to the left and right striata. The pigs in groups 3, 4, and 5 are grafted with fetal mesencephalic porcine tissue into the striatum, using similar stereotactic techniques (TPL). All pigs receive the same sequence of PET scans again 4 and 8 months after the grafting or sham surgery. After the final PET scans, a final Tl-weighted MR scan is obtained. The pigs are then killed by pentobarbital overdose and immediately transcardially perfused with 4 1 of cold 4% paraform aldehyde in 0.15 M Sorensens phosphate buffer, after clamping of the descending aorta. Within 1 h of perfusion, the brain is removed for postfixation and histological examination. Grafted Tissue: The grafted tissue had been prepared according to methods described previously (14) . Briefly, embryonic porcine brains were rapidly removed and placed in cold GEY's (GIBCO BRL) balanced salt solution (GBSS) with 1 ml of 50% D-glucose/100 ml. The ventral mesencephalon was dissected under sterile condi tions and transferred to a dish containing fresh medium prior to grafting. Each graft consisted of chopped tissue blocks, from one hemiventral mesencephalon. Each pig in groups 3, 4, and 5 received four such grafts in each striatum (i.e., mesencephalic tissue from four embryos grafted to each minipig). In normal pigs, the number of tyrosine hydroxylase-immunoreactive neurons in substantia nigra ranges from 10,000 to 16,000 (45) . HiB5 cells: Pigs in group 5 receive co-grafts with an immortalized temperaturesensitive HiB5 cell line genetically engineered to secrete 5-20 ng GDNF/10 5 cells/18 h in cell culture. The parental HiB5 cell line was derived from the rat hippocampus (41) . Each co-graft consists of a 7-ui cell suspension containing 300,000 GDNF-releasing HiB5 cells. Transplantation Procedure: Using a stereotaxic apparatus, the glass cannulae mounted on a 50-pl Hamilton syringe were passed through the dura mater, and were placed bilaterally in two adjacent regions of the anterior striatum and two adjacent regions of the posterior striata. Grafts were injected via the glass cannulae over a period of 2 min, while gradually retracting the needle approximately 4 mm. Thereafter, the needle remained in location for an additional 2 min to allow for diffusion of the vehicle, and to minimize reflux of the grafts via the needle tract. The needle was finally retracted slowly in a stepwise fashion from the brain, over a period of 1 min. The bore holes were filled with an autograft of bone granulate that was fixed in place by coagulated blood. The pigs were given postoperative care and preemptive analgesia to prevent pain and infection. The daily MPTP doses (mg/kg, SC) given over a 22-day period to the eight MPTP-treated minipigs.
for that day (42) . Control animals received 0.1 ml/kg of saline by SC injection. Over a 22-day period, the eight MPTP-treated minipigs received an average total dose of MPTP of 6.6 ± 1.4 mg/kg (see Table 1 ). The final product was synthesized in less than 30 min.
BEHAVIORAL RATING
The specific activity of the [ n C]NS-2214 was >50 GBq/ pmol at the end of synthesis, and the radiochemical pu rity was greater than 98% (22) .
[0-methyl-"C]Raclopride (["Cjraclopride) was syn thesized by methylation of the desmethylated precursor analogue with ["Cjmethyl iodide (15) . The specific ac tivity was about 60 GBq/pmol and the radiochemical purity higher than 95%.
PHARMACOLOGICAL PROCEDURES
Extracerebral dopa decarboxylase activity was inhib ited by pretreatment with carbidopa (150 mg, Merck
Sharp & Dohme). Carbidopa was dissolved in 30 ml saline by slow heating, and then cooled and adminis tered as a slow (2 min) IV bolus 30 min before FDOPA injection (7, 11) .
PET PROCEDURE
Dynamic head images were obtained using a Sie- 
Positron Emission Tomograms
The summed PET images were registered to each pig's individual MR image, using manual registration with a reference point source and a 7-parameter fit (44) . We assumed that FDA and its deaminated metabo lites were trapped in the basal ganglia for the duration of the PET recording. Compartment analysis of the rate of decarboxylation of FDOPA to FDA in striatum was accomplished by the mathematical procedure of nonlin ear regression, described in detail elsewhere (27, 32) . To simplify and constrain the calculation, we also assumed that the blood-brain barrier permeabilities to the plasma metabolite 3-0-methyl-6-[ 18 F]fluorodopa (OMFD) and
FDOPA had a fixed ratio (q = 1.5) everywhere in the brain (34) . The physical distribution of FDOPA in brain tissue (V°e, ml g"') was estimated in the cerebellum, where the rate of FDA synthesis was assumed to be zero. Using these constraints, a simple two-compartment model was fitted to the brain tissue time-radioactivity curves recorded in striatum for 60 min. This fitting pro vided estimates of three parameters in striatum; the ap parent volume of arterial plasma (V p , ml g" 1 ), the rate of transfer across the blood-brain barrier (K^, ml g~' min 1 ), and the rate constant of FDOPA decarboxylation (£?, min" 1 ) by the enzyme DOPA decarboxylase (Fig. 2) .
Data and Image Analysis of [" CJNS-2214, a Catecholamine Transporter Ligand
In the case of [ n C]NS-2214, methods for the kinetic analysis of its brain uptake have not been reported pre viously. In preliminary studies, we applied the same two-compartment model that we used to analyze the up take kinetics of the dopamine D 2 receptor antagonist Figure 2 . The FDOPA compartment model. Circulating FDOPA is 0-methylated by catechol-O-methyltransferase (COMT,) at rate k D } (min"') to form the metabolite OMFD, which is eliminated from circulation at rate k M \ (min -1 ). OMFD and FDOPA in circulation are reversibly transferred across the blood-brain barrier with unidirectional clearances and K 0 , (ml g~' min"'), and brain-blood clearance rate constants k M 2 and k° (min"'). Within brain tissue, FDOPA is metabolised by dopa decarboxylase at rate constant kl (min"'). The decarboxylated product 6-[" i F]fluorodopamine (FDA) is stored in vesicles and/or undergoes decomposition catalyzed by monoamine oxidase (MAO) or cerebral COMT at a net rate constant k D j (min 1 ) to form the acidic metabolites 6-[ l8 F]fluoro-dihydroxyphenylacetic acid (FDOPAC) and 6-[ l8 F]fluorohomovanillic acid (FHVA), which diffuse together from brain at rate constant fc 9 (min 1 ). In the study, we have assumed that FDA and its acidic metabolites occupy a single compartment, and are retained in brain during the PET scan, and that the rate of O-methylation of FDOPA in brain (kl, min" 1 ) is negligible (8) .
assumed to be irreversible, as originally described by Sokoloff et al. (52) for the enzymatic trapping of deoxyglucose. Using the metabolite-corrected arterial concen tration curve as the input function for a nonlinear regres sion procedure, we estimated four parameters: the vascular volume of tracer distribution in brain (V p , ml g~'), the blood-brain barrier clearance coefficient (K u ml ml"' min -1 ), the rate constant for transfer of tracer from the brain back to the circulation (k 2 , min" 1 ), and the rate constant for the irreversible binding (& 3 , min" 1 ) to catecholamine uptake sites. We also calculated the total net steady-state clearance coefficient (K, ml g -1 min -1 ) as described for deoxyglucose (26) . The indexes k 3 and K are proportional to the density of the catecholamine uptake sites.
Data and Image Analysis of ["CJRaclopride, a Dopamine D 2 Receptor Ligand
In the case of [''CJraclopride, the uptake data in stria tum were analyzed by comparison with cerebellum, a region devoid of dopamine receptors. This comparison allowed us to calculate a binding potential (P B ) for ["CJraclopride, which is a measure of the number of dopamine D 2 -like antagonist binding sites, the majority of which are postsynaptic to the dopamine innervation. The magnitude of P B is equivalent to the ratio of bound and free ligand (B/F ratio) determined in vitro at equilib rium (19) , and is an index of the maximal binding, B max . Calculation of the binding potential P B was performed indirectly and directly using one-and two-tissue com partment analysis of tissue time-activity curves, as de scribed previously by Lammertsma (33) . A population mean metabolite correction was applied to all arterial plasma input functions. A kinetic analysis described by Gjedde (24) , employing a reference tissue input func tion, rather than the uncertain arterial input, was also applied to the data (18) .
CLINICAL FINDINGS
The mean clinical parkinsonism score for the present group of eight MPTP-intoxicated pigs was 6 out of a maximum of 12 (Fig. 3) . This score indicates a moderate degree of severity of symptoms, which could be roughly equivalent in disability to Parkinson's disease Hoehn and Yahr stage I-II.
PET FINDINGS
Presynaptic Measurements
Based upon results from the first year of this study, neither the decarboxylation rate constant for FDOPA (£?) nor the net FDOPA influx (K) in striatum show a complete separation between control and MPTP-intoxi cated groups (Fig. 4) . However, the mean magnitude of Figure 3 . The mean parkinsonian score in a group of (n = 8) minipigs intoxicated with MPTP. The parkinsonian score is reported for a 6-week period beginning just prior to the first intoxication until just prior to the grafting procedure. The score is calculated from the composite assessment of mobility, rigidity, and coordination, to a maximum of 12 in normal pigs (bar = +SEM).
kj in striatum was 33% lower in the MPTP-intoxicated group than in the control group, while the mean magni tude of K was reduced by 25% ( Table 2 ). This means that the decarboxylation capacity of striatum was re duced by one third by the MPTP intoxication producing mild impairment.
Qualitatively, the rates of binding of ["C]NS-2214 to catecholamine uptake sites (k } ) were more distinctly impaired in the MPTP-intoxicated group (Fig. 5 ) than were the indices for FDOPA trapping. The mean magni tude of the estimate of k } for ["CJNS-2214 was reduced by 62% in the MPTP-treated group, while the mean magnitude of K was not significantly decreased by the treatment ( Table 2 ). We conclude that the number of catecholamine uptake sites on striatal dopamine fibers was reduced by 62% by the MPTP intoxication. Con comitant reductions in K, which is weighted towards the magnitude of unidirectional blood-brain clearance, were obscured by the high permeability of this tracer to the blood-brain barrier.
Postsynaptic Measurements
The mean value of P B for ["CJraclopride in striatum was 20% higher when calculated from the one-and twotissue compartment models than by the new reference tissue model. However, the standard deviation of the es timate of P B calculated for the compartment models was relatively large compared to that derived from the new reference tissue analysis (Fig. 6 ). There was no signifi cant difference between the ["CJraclopride P B of the two The effect of MPTP intoxication on the kinetics of the net blood-brain clearance (AT, ml g~' min 1 ) of FDOPA and to catecholamine uptake sites. The latter index was more profoundly reduced in the present group of pigs. The mean magnitude and the variance of the present esti mates of &° in striatum of normal adult Gottingen mini pigs were close to our earlier estimates obtained in young Danish Landrace pigs (12) . When evaluating re sults of the present preliminary report, the small number of subjects must be considered (11) . However, the mag nitude of the reduction of k% for FDOPA in the present study is very comparable to the range of relative de- 1.53 ± 0.18 p = 0.0813 p = 0.3631 p = 0.4225
DISCUSSION
The effect of MPTP intoxication on the Pn of [ n C]raclopride to dopamine D2 receptors was estimated in pig striatum by three different kinetic methods in (n = 4) striata from two PET scans of control pigs and in (n = 16) striata from eight PET scans of MPTP-intoxicated pigs. A one-tailed r-test was applied to the data.
clines reported for patients with mild idiopathic Parkin son's disease (8) . This suggests that the present methods for MPTP intoxication of pigs provide an adequate model for mildly advanced Parkinson's disease. Dis crepancies between the extent of dopamine depletion during normal aging of humans and the unaffected de carboxylation rate estimated by PET have led to the sug gestion that DOPA decarboxylase activity might be upregulated in the partially denervated striatum (31) . Consistent with this suggestion, we note a greater effect of the MPTP intoxication on an index of innervation density (["C]NS-2214 binding, -62%) than on the DOPA decarboxylation rate (-33%). Likewise, others have reported that a dopamine uptake site ligand ["C]RTI-32 is a sensitive indicator of the dopamine de nervation in early stages of idiopathic Parkinson's dis ease (28) .
The properties of the ["C]NS-2214 in vivo have not hitherto been reported. In vitro, this compound inhibits the binding of [ 3 H]WIN 35,428 to dopamine uptake sites in membranes at concentration in the nanomolar range. Its chemical structure is similar to that of the other tropane analogues that have been investigated as SPECT or PET tracers of monoamine uptake sites. The details of the kinetic analysis shall be reported separately. In brief, we note a very high permeability of [ n C]NS-2214 to the blood-brain barrier, close to the upper limit estab lished by the cerebral perfusion rate. The magnitude of the estimate of the net influx (K) is therefore very high, relative to the magnitude of the rate constant for associa tion with the catecholamine uptake sites. For this reason, the magnitude of K was not highly sensitive to the MPTP depletion; a 62% reduction in the binding rate constant /c 3 was associated with an observed 20% decline in K, which was not statistically significant.
The PET images reveal an extensive accumulation in all brain regions, attributable in part to the high bloodbrain equilibrium distribution volume (25 ml g~') com mon to lipophilic drugs. However, specific binding com ponents were detected in all brain regions examined, including the cerebellum. The highest specific associa tion rate constant (0.05 min" 1 ) was observed in the nor mal striatum. As such, the pattern of binding in vivo resembles that of the nonspecific catecholamine uptake site ligand [ 3 H]mazindol (49) . In the continuation of the present study, we shall exploit the ambivalent property of [ n C]NS-2214 to simultaneously determine the effects of MPTP intoxication on dopamine uptake sites in stria tum and noradrenaline uptake sites in other regions, in cluding cerebral cortex, thalamus, and cerebellum.
The estimate of the dopamine D 2 -like receptor bind ing potential, proportional to the receptor concentration, was not significantly changed by the MPTP intoxication, regardless of which kinetic model was employed for analysis. However, there was trend towards increased binding, which has been documented in previous studies (16, 50) . In general, an increased P B for ["Cjraclopride in living parkinsonian striatum could be attributed to reduced competition from endogenous dopamine, or upregulation of postsynaptic receptors in response to de nervation. However, the present failure to detect signifi cant changes in D 2 receptors could be due to the limited number of experimental subjects. Upon completion of this study, we will use correlation analysis to test for covariance between the several markers for dopamine innervation.
In this report we present a review of the experimental protocol scheduled for completion during the year 2000. Upon completion, this study shall constitute a highly de tailed investigation of the biochemical, physiological, neuroanatomical, and behavioral effects of MPTP intox ication in the minipig. The longitudinal design of the study shall be used to assess the magnitude and stability of neurochemical changes occurring following the graft ing of fetal mesencephalic dopamine neurons. In addi tion, the present experimental design is intended to as sess the benefits of immunosuppression and co-grafting with transformed cells secreting GDNF. 
